Five cases of a very rare blood disorder "capillary leak syndrome", in people who have received the Covid-19 vaccine developed by AstraZeneca are being reviewed by the European Medicines Agency. | Poal: Say what you want.

Welcome • User Guide
ToS • Privacy • Canary
Donate • Bugs • License

©2026 Poal.co

611

•

Five cases of a very rare blood disorder "capillary leak syndrome", in people who have received the Covid-19 vaccine developed by AstraZeneca are being reviewed by the European Medicines Agency. (archive.is)

https://www.rt.com/news/520631-ema-blood-condition-astrazeneca-vaccine/

https://www.rt.com/news/520631-ema-blood-condition-astrazeneca-vaccine/

(post is archived)

You are currently inside a comment thread.

Click here to see all the comments (1).

[–] • 0 pt

"...expected result in a population sample of this size..."

link